Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances R Levin

Showing results (181-190 of 262) with videos related to

Pageof 27
Sort By:
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Women'S Health Reports (New Rochelle, N.Y.)|February 26, 2024
Correlates of Unmet Need for Modern Contraception Among Reproductive-Aged Women Involved in New York City Criminal Legal SystemsMelissa N Slavin, Brooke S West, Deanna Schreiber-Gregory, et al.
Journal of Attention Disorders|July 25, 2024
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled TrialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
Addiction (Abingdon, England)|December 2, 2022
COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systemsNoa Krawczyk, Bianca D Rivera, Cale Basaraba, et al.
JAMA Network Open|May 11, 2022
Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use DisorderCarrie M Mintz, Kevin Y Xu, Ned J Presnall, et al.
Drug and Alcohol Dependence|July 21, 2023
Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorderJeremy D Kidd, Sabrina L Smiley, Phillip O Coffin, et al.
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.
BMJ Open|December 30, 2020
Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic painChinazo O Cunningham, Joanna L Starrels, Chenshu Zhang, et al.
Drug and Alcohol Dependence Reports|February 27, 2023
Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary studyWilfrid Noël Raby, Matthew Heller, Demetrios Milliaressis, et al.
The American Journal of Psychiatry|January 11, 2017
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus BuprenorphineMaria Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Pageof 27

Showing results (181-190 of 262) with videos related to

Sort By:
Pageof 27
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Women'S Health Reports (New Rochelle, N.Y.)|February 26, 2024
Correlates of Unmet Need for Modern Contraception Among Reproductive-Aged Women Involved in New York City Criminal Legal SystemsMelissa N Slavin, Brooke S West, Deanna Schreiber-Gregory, et al.
Journal of Attention Disorders|July 25, 2024
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled TrialFrances R Levin, John J Mariani, Martina Pavlicova, et al.
Addiction (Abingdon, England)|December 2, 2022
COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systemsNoa Krawczyk, Bianca D Rivera, Cale Basaraba, et al.
JAMA Network Open|May 11, 2022
Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use DisorderCarrie M Mintz, Kevin Y Xu, Ned J Presnall, et al.
Drug and Alcohol Dependence|July 21, 2023
Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorderJeremy D Kidd, Sabrina L Smiley, Phillip O Coffin, et al.
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.
BMJ Open|December 30, 2020
Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic painChinazo O Cunningham, Joanna L Starrels, Chenshu Zhang, et al.
Drug and Alcohol Dependence Reports|February 27, 2023
Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary studyWilfrid Noël Raby, Matthew Heller, Demetrios Milliaressis, et al.
The American Journal of Psychiatry|January 11, 2017
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus BuprenorphineMaria Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Pageof 27